Clinical Trial Detail

NCT ID NCT03380871
Title A Personalized Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Neon Therapeutics, Inc.
Indications

lung non-small cell carcinoma

Therapies

Carboplatin + NEO-PV-01 + Pembrolizumab + Pemetrexed Disodium + Poly ICLC

Age Groups: adult senior

No variant requirements are available.